Amphastar Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 27.72 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.18B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Glucagon for injection emergency kit; Enoxaparin, an injectable form of low molecular weight heparin for the preven...